{"id":"W4367303940","doi":"10.1212/wnl.0000000000202145","title":"Lack of Rebound Disease Activity in Participants with Relapsing Multiple Sclerosis Following Placebo Run-out in the Tolebrutinib Phase 2b Trial (P6-3.006)","year":2023,"lang":"en","type":"article","venue":"Neurology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Michael's Hospital; NeuroRx Research (Canada); University of Toronto; Montreal Neurological Institute and Hospital; McGill University; University of British Columbia","funders":"","keywords":"Multiple sclerosis; Placebo; Disease; Medicine; Internal medicine; Immunology; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006656718,0.0005937531,0.001416395,0.0002370621,0.0005711273,0.0008542166,0.000488344,0.001121455,0.007620947],"category_scores_gemma":[0.004391705,0.0002442775,0.001576588,0.000366693,0.0003893722,0.0009723178,0.0003341238,0.001747016,0.0008404864],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004172263,"about_ca_system_score_gemma":0.0007446944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007593521,"about_ca_topic_score_gemma":0.002149519,"domain_scores_codex":[0.9980081,0.001218889,0.0001620069,0.0002349181,0.0001955524,0.0001805348],"domain_scores_gemma":[0.9977263,0.0006953702,0.0007910315,0.0002056488,0.0002562225,0.0003254741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8519129,0.003066193,0.03234809,0.002617973,0.005605034,0.0002261253,0.0003214824,0.0002553108,0.009986538,0.0004013865,0.005180407,0.08807854],"study_design_scores_gemma":[0.3760356,0.2656873,0.3172846,0.0009640717,0.0112929,0.001083469,0.0003144039,0.001262284,0.007853647,0.001964491,0.01615017,0.0001070845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9661393,0.01479457,0.001332731,0.001056019,0.0004236948,0.002611077,0.004847275,0.0002270077,0.008568335],"genre_scores_gemma":[0.9917223,0.001168241,0.00107899,0.0007265249,0.0001129831,0.001717139,0.001508046,0.00002480464,0.001940912],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007620947,"threshold_uncertainty_score":0.03520453,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.145877581144314,"score_gpt":0.3641390942754008,"score_spread":0.2182615131310868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}